Company intelligence / Profile preview
Amplo Biotechnology
Towson, Maryland, USAamplobiotechnology.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
01
Overview
Amplo’s lead program AMP-101 has demonstrated promising preclinical pharmacology and safety data in mouse models of Dok7 CMS. The therapy showed functional correction of the disease phenotype and extended lifespan in animal studies. Manufacturing at scale with high purity has been achieved. AMP-201 also shows efficacy in preclinical models for ColQ CMS. Both programs are expected to enter clinical trials soon.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- Gene therapyAdeno-associated virus (AAV)-based gene therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Nagoya University/Professor Kinji Ohno’s laboratory – exclusive license for AAV-ColQ data supporting AMP‑201 developmentUniversity of California Davis/Professor Ricardo Maselli – collaboration on AMP‑201 development and clinical translationUniversity of Tokyo – exclusive license agreement for DOK7/AAV technology supporting AMP‑101 development
Beyond the preview
Go deeper on Amplo Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amplo Biotechnology.